Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone VK-0Z8P) SynExpress C-G-cF-X Modified CD8+ T cells (CAT#: ITS-1224-CR292)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone VK-0Z8P). We employs the AAV (CMV-GFP-c-Fos-XbaI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
VK-0Z8P
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Microcarrier Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving